The Future of Violence Against Women
By Sujatha Jesudason,
US Women Without Borders
| 02. 21. 2006
Human Rights & the New Genetics
I was born into a culture that embraces confusing messages about the worth and value of women. I grew up in an India where a woman such as Indira Gandhi could become a formidable leader, and yet female infants were routinely killed or starved because they were deemed less valuable than boys. This contradiction played out in my family where smart and competent women who made a difference in the world continued to live with men who abused them, or attempted suicide when their husbands left them. The female role models in my life oscillated between these radical extremes: powerful agents and value-less victims. For as much as I have resisted, this confusion has been a central struggle in my life; I have worked to believe that there is a place for me in this world, that I have a right to enjoyment and happiness, that I matter, and that I have the power to make a difference.
I began working to end violence against women nearly fifteen years ago when I realized that violence is one of the key...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...